Fresonem

Trusted Partner in Critical Hours

  • An ultra-broad spectrum carbapenem. Meropenem is an intravenous broad spectrum beta-lactam antibacterial agent of the carbapenem class. Meropenem single agent therapy provides broad coverage in complicated infections.

Meropenem injection IP is indicated for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms:

  • LowerRespiratory Tract Infections
  • Urinary Tract Infections, including complicated infections
  • Intra-abdominal Infections
  • Gynaecological Infections
  • Skin and Skin Structure Infections
  • Meningitis
  • Septicaemia
  • Empiric treatment, including initital monotherapy, for presumed bacterial infections in hostcompromised, neutropenic patients.

Because of its broad spectrum of bactericidal activity against Gram-positive and Gram-negative aerobic

and anaerobic bacteria, Meropenem injection IP is effective for the treatment of polymicrobial infections.

  • Meropenem injection 500mg:

          Supplied as clear 20 ml USP Type 1 glass vial with grey bromobutyl rubber closure and aluminium flip off seal. Vials are packed individually in outer carton along with pack insert.

  • Meropenem injection 1000mg:

          Supplied as clear 30 ml USP Type 1 glass vial with grey bromobutyl rubber closure and aluminium flip off seal. Vials are packed individually in outer carton along with pack insert.

InfectionDose to be administered
every 8 hours
Severe pneumonia including hospital and ventilator-associated pneumonia.500 mg or 1 g
Broncho-pulmonary infections in cystic fibrosis2 g
Complicated urinary tract infections500 mg or 1 g
Complicated intra-abdominal infections500 mg or 1 g

Intra- and post-partum infections

500 mg or 1 g

Complicated skin and soft tissue infections500 mg or 1 g
Acute bacterial meningitis2 g
Management of febrile neutropenic patients1 g

 

Fresonem 500 TM

Meropenem Injection IP 500mg

Each Vial Contains:

Meropenem IP (Sterile) equivalent to Anhydrous Meropenem ..................500mg

SodiumCarbonate IP (Sterile) equivalent to Sodium (as buffer) ..............45.1mg

Fresonem 1000 TM

Meropenem Injection IP 1000mg

Each Vial Contains :

Meropenem IP (Sterile) equivalent to Anhydrous Meropenem ................ 1000mg

SodiumCarbonate IP (Sterile) equivalent to Sodium (as buffer) ..............90.2mg